Literature DB >> 26446305

Bent bone dysplasia (BBD)-FGFR2 type: the radiologic manifestations in early gestation.

Atsuhiko Handa1, Yuka Okajima2, Noriko Izumi3, Michiko Yamanaka3, Yasuyuki Kurihara2.   

Abstract

Bent bone dysplasia-fibroblast growth factor receptor 2 type (BBD-FGFR2) is a recently identified skeletal dysplasia caused by specific FGFR2 mutations, characterized by craniosynostosis and prenatal bowing of the long bones. Only a few cases have been published. We report an affected fetus terminated at 21 weeks of gestation. The clinical and radiologic manifestations mostly recapitulate previous descriptions; however we suggest additional hallmarks of this disorder in early gestation. These hallmarks include distinctive short, thick clavicles and wavy ribs, as well as vertebral bodies that showed striking anteroposterior shortening. Femoral fractures were also present in our case. Although craniosynostosis is a hallmark of the disease, clinicians should be aware that craniosynostosis might not be readily apparent on plain films early in gestation.

Entities:  

Keywords:  Bent bone dysplasia; Bowed long bones; Craniosynostosis; FGFR2; Fetus; Fibroblast growth factor receptor 2 type (BBD-FGFR2); Radiography; Skeletal dysplasia

Mesh:

Substances:

Year:  2015        PMID: 26446305     DOI: 10.1007/s00247-015-3465-y

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  7 in total

Review 1.  [Osteoglophonic skeletal dysplasia--a variant of generalized fibrous dysplasia? Case report and review of the literature].

Authors:  H Stöss; E Sieber; H U Tietze
Journal:  Pathologe       Date:  1991-05       Impact factor: 1.011

2.  The postnatal features of bent bone dysplasia-FGFR2 type.

Authors:  Richard H Scott; Cathy Meaney; Lucy Jenkins; Alistair Calder; Jane A Hurst
Journal:  Clin Dysmorphol       Date:  2014-01       Impact factor: 0.816

3.  Bent bone dysplasia-FGFR2 type, a distinct skeletal disorder, has deficient canonical FGF signaling.

Authors:  Amy E Merrill; Anna Sarukhanov; Pavel Krejci; Brian Idoni; Natalia Camacho; Kristine D Estrada; Karen M Lyons; Hannah Deixler; Haynes Robinson; David Chitayat; Cynthia J Curry; Ralph S Lachman; William R Wilcox; Deborah Krakow
Journal:  Am J Hum Genet       Date:  2012-03-01       Impact factor: 11.025

4.  Mutations in SEC24D, encoding a component of the COPII machinery, cause a syndromic form of osteogenesis imperfecta.

Authors:  Lutz Garbes; Kyungho Kim; Angelika Rieß; Heike Hoyer-Kuhn; Filippo Beleggia; Andrea Bevot; Mi Jeong Kim; Yang Hoon Huh; Hee-Seok Kweon; Ravi Savarirayan; David Amor; Purvi M Kakadia; Tobias Lindig; Karl Oliver Kagan; Jutta Becker; Simeon A Boyadjiev; Bernd Wollnik; Oliver Semler; Stefan K Bohlander; Jinoh Kim; Christian Netzer
Journal:  Am J Hum Genet       Date:  2015-02-12       Impact factor: 11.025

5.  Bent bone dysplasia syndrome reveals nucleolar activity for FGFR2 in ribosomal DNA transcription.

Authors:  Cynthia L Neben; Brian Idoni; Joanna E Salva; Creighton T Tuzon; Judd C Rice; Deborah Krakow; Amy E Merrill
Journal:  Hum Mol Genet       Date:  2014-06-06       Impact factor: 6.150

6.  Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation.

Authors:  Kenneth E White; Jose M Cabral; Siobhan I Davis; Tonya Fishburn; Wayne E Evans; Shoji Ichikawa; Joanna Fields; Xijie Yu; Nick J Shaw; Neil J McLellan; Carole McKeown; David Fitzpatrick; Kai Yu; David M Ornitz; Michael J Econs
Journal:  Am J Hum Genet       Date:  2004-12-28       Impact factor: 11.025

Review 7.  Osteoglophonic dysplasia: review and further delineation of the syndrome.

Authors:  S Sklower Brooks; G Kassner; Q Qazi; M J Keogh; R J Gorlin
Journal:  Am J Med Genet       Date:  1996-12-11
  7 in total
  2 in total

1.  Clinical and radiographic delineation of Bent Bone Dysplasia-FGFR2 type or Bent Bone Dysplasia with Distinctive Clavicles and Angel-shaped Phalanges.

Authors:  Deborah Krakow; Daniel H Cohn; William R Wilcox; Grace J Noh; Leslie J Raffel; Anna Sarukhanov; Margarita H Ivanova; Moise Danielpour; Dorothy K Grange; Alison M Elliott; Jonathan A Bernstein; David L Rimoin; Amy E Merrill; Ralph S Lachman
Journal:  Am J Med Genet A       Date:  2016-05-30       Impact factor: 2.802

Review 2.  Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation Related Syndromic Craniosynostosis.

Authors:  Saïd C Azoury; Sashank Reddy; Vivek Shukla; Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2017-11-02       Impact factor: 6.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.